† Study has passed its completion date and status has not been verified in more than two years.
A Study of the Immunogenicity of M. Bovis BCG, Delivered Intradermally in Healthy Volunteers
A Study of the Immunogenicity of BCG, Delivered Intradermally in Healthy Volunteers
Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG
T−Cell Turnover Following Vaccination With MVA85A
A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both
Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB.
The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV